Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
about
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.Late effects of blood and marrow transplantation.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.The role of plasmapheresis in critical illness.Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children.No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab.Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.
P2860
Q30276550-FE3B4C25-51FC-4292-916D-070B6E3AA38DQ33395998-391169FB-3EC6-4D12-8AB7-321BA7A6D1EDQ33398627-1E566B32-B463-453B-8617-D8319B0886C2Q33413498-01B891C0-43DB-4079-8547-49F0FD43485DQ33424153-1794089E-DCB0-4B48-994A-F847CEBC6F43Q33574136-86BECE78-0D7A-4807-ADD0-E54DB5DF4422Q34122035-9948F120-058A-4B9B-A656-02370DC42AF9Q36053839-9C8E58AC-67C7-4EBC-ACAB-C4A69FBFEA3CQ43241790-1AB10F34-F13E-4055-8D8D-401C29462412Q50025315-AB0BAB54-D859-44DE-86F4-9DDD451FC686Q50622232-8A47A231-0EA5-4A22-8747-0851335FF2B5
P2860
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Transplant-associated microang ...... ors and response to treatment.
@ast
Transplant-associated microang ...... ors and response to treatment.
@en
type
label
Transplant-associated microang ...... ors and response to treatment.
@ast
Transplant-associated microang ...... ors and response to treatment.
@en
prefLabel
Transplant-associated microang ...... ors and response to treatment.
@ast
Transplant-associated microang ...... ors and response to treatment.
@en
P2093
P1476
Transplant-associated microang ...... ors and response to treatment.
@en
P2093
Ana Aleman
Betul Oran
Caimiao Wei
Elizabeth Shpall
Martin Korbling
Michele Donato
Michelle A Detry
Paolo Anderlini
Richard E Champlin
Uday Popat
P304
P356
10.1016/J.BBMT.2006.11.020
P577
2007-02-08T00:00:00Z